The Surge in Drug & Alcohol Consumption Boost the Global Drug Screening Market Growth from Stevesmith's blog

In 2022, the size of the Global Drug Screening Market was evaluated at USD 7.5 billion, and is expected to grow at a CAGR of around 11.33% from 2025 to 2030. As per the report of the Drug Report 2021 released by the United Nations Office on Drugs and Crime in 2022, there has been a remarkable rise of 22% in the number of drug users across the world. Moreover, around 20 million people, representing 0.4% of the world population, were reported to have consumed cocaine.

As drug consumption continues to rise among the population, the demand for drug screening services is anticipated to expand, subsequently fostering significant growth of the industry during the study period.

The Advent of AI-based Drug Screening Process Fuels the Global Drug Screening Industry Growth

As AI technology is becoming more advanced and accessible, AI-based screening methods are opening up new possibilities for drug discovery. A researcher’s team from the University of Central Florida has developed an innovative AI-based screening method that can notably facilitate the procedure of identifying promising drug candidates. Through this method, the researchers achieved an impressive accuracy of about 97% in their prediction.

With such favorable advancements, the drug screening market is poised to expand significantly in the forthcoming years.

Drug Screening in Workplace Gained Traction to Make Sure a Safe & Drug-Free Environment for Employees

On the basis of end-users, the Global Drug Screening Market is categorized into the following segments:

·       Drug Testing Laboratories  

·       Workplaces  

·       Criminal Justice & Law Enforcement Agencies  

·       Hospitals  

·       Drug Treatment Centers  

·       Individual Users  

·       Pain Management Centers  

·       Schools & Colleges 

Out of these, drug screening in workplaces has gained traction in order to ensure a safe and drug-free environment for employees and comply with regulatory needs in some industries. Pre-employment drug testing is helpful to screen potential candidates before hiring, ensuring that only drug-free candidates are brought into the workplace.

Moreover, post-accident drug testing plays a crucial role is finding the cause of workplace accidents, helping the employer to take appropriate actions. Consequently, the demand for drug screening solution has increased in the workplace across several sectors, making it a notable driving force in the overall growth of the drug screening market.

Top Market Players in the Global Drug Screening Industry

As per the latest report by MarkNtel Advisors, the leading players of the Global Drug Screening Market are:

·       Labcorp

·       Quest Diagnostics

·       Abbott Laboratories

·       Orasure Technologies

·       Alfa Scientific Designs

·       ThermoFisher Scientific

·       Dragewerk

·       Lifeloc Technologies

·       MPD Inc.

·       Omega Laboratories

·       Premier Biotech

·       Psychmedics

·       Siemens Healthineers

·       Shimadzu Corporation

·       Hoffmann-La Roche Ltd

Recent Development in the Global Drug Screening Market

In June 2023, Quest Diagnostics, Inc. (DGX)started a partnership with Coriell Life Sciences to provide pharmacogenomics testing services to specific members of medical plans. This test assesses the influence of several genes and their variations on how a person responds to medications.

North America Leads the Global Drug Screening Market by Occupying a Prominent Share of the Industry

Geographically, the Global Drug Screening Market extends across the following regions:

·       North America

·       South America

·       Europe

·       Middle East & Africa

·       Asia-Pacific

Among these, North America has emerged as the dominating region. This dominance can be accredited to multiple factors that fosters the expansion of regional drug screening practices. The rising consumption of drugs in the North American region has raised concerns about the safety and health of the public, resulting in a higher demand for effective drug screening measures.

Moreover, strict regulations on the usage of drugs boosting and operating heavy machinery again drive the adoption of drug screening technologies for accident prevention and public safety.

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India